Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian Patients

E-ISSN： 1096-9071|87|3|428-440

ISSN： 0146-6615

Source： JOURNAL OF MEDICAL VIROLOGY, Vol.87, Iss.3, 2015-03, pp. : 428-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HBV, HCV, and HBV/HCV co‐infection among HIV‐positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome

JOURNAL OF MEDICAL VIROLOGY, Vol. 90, Iss. 3, 2018-03 ,pp. : 518-525

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti‐HCV combination therapy

JOURNAL OF MEDICAL VIROLOGY, Vol. 88, Iss. 1, 2016-01 ,pp. : 86-93

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin‐28b CC genotype predicts early treatment response and CT/TT genotypes predicts non‐response in patients infected with HCV genotype 3

JOURNAL OF MEDICAL VIROLOGY, Vol. 86, Iss. 4, 2014-04 ,pp. : 707-712

John Wiley & Sons Inc

Access to resources Recommend Favorite

HBV and HCV Therapy

By Lampertico Pietro Aghemo Alessio Viganò Mauro Colombo Massimo

Viruses, Vol. 1, Iss. 3, 2009-10 ,pp. : 484-509

MDPI

Access to resources Recommend Favorite

Cyclophilin Inhibitors as a Novel HCV Therapy

By Tang Hengli

Viruses, Vol. 2, Iss. 8, 2010-08 ,pp. : 1621-1634

MDPI

Access to resources Recommend Favorite